Novartis just handed the entire Lp(a) drug class a failing grade, and Amgen is taking the worst of the punishment despite releasing promising trial results of its own on the very same morning.
One S&P 500-based ETF has quietly been outpacing both the SPY and the QQQ year after year, and the structural reason behind its edge suggests the run is far from over.
SanDisk has turned in one of the most explosive stock runs of 2026, but Wall Street and one closely watched model are now pointing in opposite directions, and the gap between them could define…
A Texas factory just handed Enphase a credible claim on the AI data-center power market, and SolarEdge surged even harder despite announcing nothing at all.
Financial planners are quietly steering families away from the Trump account's most obvious move, and the math behind their caution changes the case for funding it entirely.
Bitcoin has already bounced 23% off its August lows, but two failed attempts near $80,500 this month suggest the path back to breakeven for 2026 is far from clear. Four specific conditions would need…
Tom Lee has a precise formula for Ethereum hitting $6,000 by December, but it requires Bitcoin to do something it has never done in a single quarter before.
Palantir keeps beating Wall Street's expectations while trading at a valuation that makes most analysts flinch, and the tension between those two realities is exactly what makes its next move so hard to predict.
Hyperscalers are desperate for firm, carbon-free power and three nuclear stocks sit directly in their crosshairs, but only one of them has actual cash flow today, and the gap between the three tells you…